Results 51 to 60 of about 172,793 (249)

Training the morphological mindset: An educational framework for teaching morphological reasoning in the laboratory

open access: yesAnatomical Sciences Education, EarlyView.
The graphic summarizes the proposed shift from image recognition to morphological reasoning through an iterative process of observation, description, interpretation, integration, and questioning across anatomical, histological, and ultrastructural scales.
Katia Cortese
wiley   +1 more source

Unique laser coding technology to fight falsified medicines [PDF]

open access: yesEuropean Journal of Pharmaceutical Sciences, 2018
Based on WHO statistics, counterfeit medicines represent 10% of the global drug trade. According to Directive 2011/62/EU as regards the prevention of falsified medicines from entering into the legal supply chain, a unique identification should be put on each box of drugs to be able to track and trace them.
K. Ludasi   +5 more
openaire   +3 more sources

The use of high performance anion exchange chromatography for the detection of counterfeit pharmaceutical products using the excipient content as a marker [PDF]

open access: yes, 2015
The aim of the investigation described here was to examine the differences between genuine and counterfeit pharmaceutical products through the development of an analytical method capable of rigorously identifying the sugar-based excipients.
Suman, Mandeesh   +2 more
core   +2 more sources

Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Study design and main findings. After 1:1 propensity score matching, 60 885 PCSK9 inhibitor users and 60 885 statin‐only users with ASCVD were compared. Kaplan–Meier curves show 12‐month cumulative event‐free survival for MACE, psychiatric disease, and neurodegenerative disease.
Tianshu Gu   +7 more
wiley   +1 more source

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review

open access: yesJournal of Pharmaceutical Policy and Practice
Background: Substandard, falsified, unlicensed, and unregistered medicines pose significant risks to public health in developed and developing countries. This systematic review provides an overview of the prevalence of substandard, falsified, unlicensed,
Biset Asrade Mekonnen   +2 more
doaj   +1 more source

Tackling the problem of falsified medicines in the UK [PDF]

open access: yesPrescriber, 2018
The problem of falsified medicines entering the supply chain has grown in recent years, including in the UK. However, new initiatives such as the EU Falsified Medicines Directive are attempting to confront the issue.
openaire   +1 more source

Capacity building in medicines development and regulation in Africa—Overview on recent progress

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Despite advances in health research and digital innovation, many African countries continue to face substantial resource constraints, fragmented capacity‐building efforts and a shortage of skilled professionals in medicines development and regulatory science.
Tirhani Maluleke   +7 more
wiley   +1 more source

Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk

open access: yesFrontiers in Pharmacology
Falsified and counterfeit medicines represent a growing global public health concern and straddles business implications, and their proliferation has intensified worldwide.
Jessica Citlalli Celaya Pérez   +7 more
doaj   +1 more source

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.

open access: yesPLoS ONE, 2017
BackgroundSubstandard and falsified medical products present a serious threat to public health, especially in low- and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly
Albert Petersen   +3 more
doaj   +1 more source

Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries

open access: yesFrontiers in Medicine, 2022
IntroductionThe presence of N-nitrosamine impurities in medicines raised concerns globally as they are genotoxic and probable human carcinogens. A review of N-nitrosamine impurities in medicines provides an opportunity for National Regulatory Authorities
Patience P. Shabangu   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy